Factors predictive of early death in patients receiving high-dose CHOP (ACVB regimen) for aggressive non-Hodgkin's lymphoma: a GELA study. [electronic resource]
Producer: 20020911Description: 210-7 p. digitalISSN:- 0007-1048
- Adolescent
- Adult
- Age Factors
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biomarkers -- blood
- Cyclophosphamide -- administration & dosage
- Disease Progression
- Doxorubicin -- administration & dosage
- Female
- Hemoglobins -- analysis
- Humans
- L-Lactate Dehydrogenase -- blood
- Leukocyte Count
- Lymphoma, Non-Hodgkin -- blood
- Male
- Middle Aged
- Prednisolone -- administration & dosage
- Prognosis
- Regression Analysis
- Remission Induction
- Risk
- Serum Albumin -- analysis
- Time Factors
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.